We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » St. Jude Gets Expected Form 483, Warning Letter Still a Possibility
St. Jude Gets Expected Form 483, Warning Letter Still a Possibility
November 1, 2012
St. Jude filed an Oct. 24 Form 8-K with the SEC stating the company had received a Form 483 for observations made during a Sept. 25 to Oct. 17 FDA inspection of its Sylmar, Calif., cardiac rhythm management (CRM) plant.